FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987177532> ?p ?o ?g. }

• W2987177532 endingPage "277" @default.
• W2987177532 startingPage "266" @default.
• W2987177532 abstract "Open trials suggest phentermine/topiramate ER (PHEN/TPM-ER), food and drug administration (FDA) approved for obesity, has utility for binge eating. With no randomized controlled trials (RCTs) yet performed, this trial aimed to evaluate PHEN/TPM-ERs efficacy and safety in a crossover RCT for patients with binge-eating disorder (BED) or bulimia nervosa (BN).Participants were randomized to 12-weeks PHEN/TPM-ER (3.75 mg/23 mg-15 mg/92 mg) or placebo followed by 2-weeks drug washout, then 12-week crossover. Demographics, vitals, eating disorder behaviors, mood, and side effects were measured. Primary outcome was objective binge-eating (OBE) days/4-weeks; secondary outcomes included binge abstinence. Mixed-effect models estimated treatment effects, with fixed effects adjusting for treatment, study period, and diagnosis.The 22 adults (BED = 18, BN = 4) were female (96%), Caucasian (55%), aged 42.9 (SD = 10.1) years with body mass index = 31.1 (SD = 6.2) kg/m2 . Baseline OBE days/4-weeks decreased from 16.2 (SD = 7.8) to 4.2 (SD = 8.4) after PHEN/TPM-ER versus 13.2 (SD = 9.1) after placebo (p < .0001), with abstinence rates = 63.6% on PHEN/TPM-ER versus 9.1% on placebo (p < .0001). Weight changes = -5.8 kg on PHEN/ TPM-ER versus +0.4 kg on placebo. Drop-out = 2 (9%) on PHEN/TPM-ER and 2 (9%) on placebo, with few side effects. Vital sign changes with PHEN/TPM-ER were minimal and similar to placebo. Responses were not significantly different for BED versus BN.This first RCT to evaluate the efficacy and safety of PHEN/TPM-ER for BED/BN found this drug combination significantly more effective at reducing binge eating than placebo and well tolerated. However, with only four participants with BN, findings regarding the safety of PHEN/TPM-ER in patients with BN must be taken with caution.Clinicaltrials.gov identifier NCT02553824 registered on 9/17/2015. https://clinicaltrials.gov/ct2/show/NCT02553824." @default.
• W2987177532 created "2019-11-22" @default.
• W2987177532 creator A5005467359 @default.
• W2987177532 creator A5019894906 @default.
• W2987177532 creator A5039819447 @default.
• W2987177532 creator A5048249786 @default.
• W2987177532 creator A5056303256 @default.
• W2987177532 creator A5069838219 @default.
• W2987177532 creator A5088558119 @default.
• W2987177532 date "2019-11-13" @default.
• W2987177532 modified "2023-09-28" @default.
• W2987177532 title "A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosa" @default.
• W2987177532 cites W1537391465 @default.
• W2987177532 cites W1989431420 @default.
• W2987177532 cites W1991134429 @default.
• W2987177532 cites W2011790043 @default.
• W2987177532 cites W2032132493 @default.
• W2987177532 cites W2043688425 @default.
• W2987177532 cites W2060917291 @default.
• W2987177532 cites W2071538269 @default.
• W2987177532 cites W2071828445 @default.
• W2987177532 cites W2080796480 @default.
• W2987177532 cites W2084901616 @default.
• W2987177532 cites W2103264791 @default.
• W2987177532 cites W2132322340 @default.
• W2987177532 cites W2148690325 @default.
• W2987177532 cites W2168633245 @default.
• W2987177532 cites W2532250309 @default.
• W2987177532 cites W2761905659 @default.
• W2987177532 cites W2789597149 @default.
• W2987177532 doi "https://doi.org/10.1002/eat.23192" @default.
• W2987177532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31721257" @default.
• W2987177532 hasPublicationYear "2019" @default.
• W2987177532 type Work @default.
• W2987177532 sameAs 2987177532 @default.
• W2987177532 citedByCount "27" @default.
• W2987177532 countsByYear W29871775322020 @default.
• W2987177532 countsByYear W29871775322021 @default.
• W2987177532 countsByYear W29871775322022 @default.
• W2987177532 countsByYear W29871775322023 @default.
• W2987177532 crossrefType "journal-article" @default.
• W2987177532 hasAuthorship W2987177532A5005467359 @default.
• W2987177532 hasAuthorship W2987177532A5019894906 @default.
• W2987177532 hasAuthorship W2987177532A5039819447 @default.
• W2987177532 hasAuthorship W2987177532A5048249786 @default.
• W2987177532 hasAuthorship W2987177532A5056303256 @default.
• W2987177532 hasAuthorship W2987177532A5069838219 @default.
• W2987177532 hasAuthorship W2987177532A5088558119 @default.
• W2987177532 hasConcept C118552586 @default.
• W2987177532 hasConcept C126322002 @default.
• W2987177532 hasConcept C142724271 @default.
• W2987177532 hasConcept C168563851 @default.
• W2987177532 hasConcept C204787440 @default.
• W2987177532 hasConcept C27081682 @default.
• W2987177532 hasConcept C2776394216 @default.
• W2987177532 hasConcept C2777556793 @default.
• W2987177532 hasConcept C2777683783 @default.
• W2987177532 hasConcept C2778186239 @default.
• W2987177532 hasConcept C2778202721 @default.
• W2987177532 hasConcept C2778456266 @default.
• W2987177532 hasConcept C2780687700 @default.
• W2987177532 hasConcept C2781426410 @default.
• W2987177532 hasConcept C511355011 @default.
• W2987177532 hasConcept C544821477 @default.
• W2987177532 hasConcept C71924100 @default.
• W2987177532 hasConcept C87813604 @default.
• W2987177532 hasConcept C90924648 @default.
• W2987177532 hasConceptScore W2987177532C118552586 @default.
• W2987177532 hasConceptScore W2987177532C126322002 @default.
• W2987177532 hasConceptScore W2987177532C142724271 @default.
• W2987177532 hasConceptScore W2987177532C168563851 @default.
• W2987177532 hasConceptScore W2987177532C204787440 @default.
• W2987177532 hasConceptScore W2987177532C27081682 @default.
• W2987177532 hasConceptScore W2987177532C2776394216 @default.
• W2987177532 hasConceptScore W2987177532C2777556793 @default.
• W2987177532 hasConceptScore W2987177532C2777683783 @default.
• W2987177532 hasConceptScore W2987177532C2778186239 @default.
• W2987177532 hasConceptScore W2987177532C2778202721 @default.
• W2987177532 hasConceptScore W2987177532C2778456266 @default.
• W2987177532 hasConceptScore W2987177532C2780687700 @default.
• W2987177532 hasConceptScore W2987177532C2781426410 @default.
• W2987177532 hasConceptScore W2987177532C511355011 @default.
• W2987177532 hasConceptScore W2987177532C544821477 @default.
• W2987177532 hasConceptScore W2987177532C71924100 @default.
• W2987177532 hasConceptScore W2987177532C87813604 @default.
• W2987177532 hasConceptScore W2987177532C90924648 @default.
• W2987177532 hasFunder F4320337472 @default.
• W2987177532 hasIssue "2" @default.
• W2987177532 hasLocation W29871775321 @default.
• W2987177532 hasLocation W29871775322 @default.
• W2987177532 hasOpenAccess W2987177532 @default.
• W2987177532 hasPrimaryLocation W29871775321 @default.
• W2987177532 hasRelatedWork W2004413469 @default.
• W2987177532 hasRelatedWork W2071828445 @default.
• W2987177532 hasRelatedWork W2089441523 @default.
• W2987177532 hasRelatedWork W2103264791 @default.
• W2987177532 hasRelatedWork W2157829642 @default.
• W2987177532 hasRelatedWork W2591729171 @default.

• next